Newsfeeds Archive - Page 2 of 11

2 minute read

Axsome Depression Drug’s Commercial Success, Pipeline Potential Undervalued, Analyst Says

January 25, 4:08 PM

Axsome Therapeutics' growth potential with RBC Capital's optimistic coverage. Auvelity's rapid Rx growth projects sales of $296M in 2024, outperforming estimates.

AXSM

3 minute read

Analyst Ratings

The Analyst Landscape: 6 Takes On Axsome Therapeutics

By Benzinga Insights

January 16, 11:00 AM

Across the recent three months, 6 analysts have shared their insights on Axsome Therapeutics (NASDAQ:AXSM), expressing a variety…

AXSM

2 minute read

Analyst Ratings

Analyst Expectations for Axsome Therapeutics’s Future

By Benzinga Insights

November 7, 1:00 PM

Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

AXSM

2 minute read

Axsome’s Strategy on Payer Coverage Slowly Pays Off, Depression Drug Sales Show Growth

By Vandana Singh

November 6, 4:22 PM

Axsome Therapeutics Inc (NASDAQ: AXSM) reported Q3 revenues of $57.8 million, up 244% Y/Y, beating the consensus of $54.75 m

AXSM

12 minute read

Earnings

Earnings Scheduled For November 6, 2023

By Benzinga Insights

November 6, 9:24 AM

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

AAON

2 minute read

Analyst Ratings

Analyst Ratings for Axsome Therapeutics

By Benzinga Insights

September 25, 3:00 PM

Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

AXSM

1 minute read

Analyst Ratings

Analyst Ratings for Axsome Therapeutics

By Benzinga Insights

August 11, 9:00 AM

Within the last quarter, Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

AXSM

2 minute read

Analyst Ratings

Expert Ratings for Axsome Therapeutics

By Benzinga Insights

July 17, 3:00 PM

Over the past 3 months, 11 analysts have published their opinion on Axsome Therapeutics (NASDAQ:AXSM) stock. These analysts…

AXSM

2 minute read

Baidu To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Monday

By Lisa Levin

July 17, 7:52 AM

Keybanc boosted the price target for Camping World Holdings, Inc. (NYSE: CWH) from $28 to $36. Keybanc analyst Noah Zatzkin maintained an Overweight rating. Camping World shares rose 1.4% to $32.04 in pre-market trading.

AXSM

3 minute read

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

June 28, 1:04 PM

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.

ACHR